MeiraGTx Holdings (MGTX) Cash from Investing Activities (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Cash from Investing Activities came in at -$1.1 million in Q4 2025, up 10.59% YoY from -$984708.2 in Q4 2024, and down 99.09% on a QoQ basis from -$547000.0 in Q3 2025.
Analysis
MeiraGTx Holdings (MGTX) Cash from Investing Activities (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Cash from Investing Activities data on file, last reported at -$1.1 million in Q4 2025.
- Quarterly Cash from Investing Activities rose 10.59% year-over-year to -$1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.1 million (down 117.49% YoY) and the FY2025 annual result came in at -$4.1 million, down 117.49% from the prior year.
- Cash from Investing Activities fell to -$1.1 million in Q4 2025, from -$547000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $51.2 million in Q4 2023 to a low of -$25.4 million in Q4 2021.
- A 5-year average of -$2.7 million and a median of -$4.3 million in 2023 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2021 — Cash from Investing Activities sank 367.49% — and 2023, when it jumped 702.66%.
- Tracing MGTX's Cash from Investing Activities over 5 years: stood at -$25.4 million in 2021, then soared by 66.53% to -$8.5 million in 2022, then jumped by 702.66% to $51.2 million in 2023, then plunged by 102.38% to -$1.2 million in 2024, then climbed by 10.59% to -$1.1 million in 2025.
- The last three Cash from Investing Activities figures came in at -$1.1 million (Q4 2025), -$547000.0 (Q3 2025), and -$761000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 329.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -1.66 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -49.35 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -363.46 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -229.72 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 24.51 Mn |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1.09 Mn |
| Sep 30, 2025 | -547,000.00 |
| Jun 30, 2025 | -761,000.00 |
| Mar 31, 2025 | -1.71 Mn |
| Dec 31, 2024 | -1.22 Mn |
| Sep 30, 2024 | -1.31 Mn |
| Jun 30, 2024 | -1.33 Mn |
| Mar 31, 2024 | 27.34 Mn |
| Dec 31, 2023 | 51.18 Mn |
| Sep 30, 2023 | -3.56 Mn |
| Jun 30, 2023 | -4.98 Mn |
| Mar 31, 2023 | -8.61 Mn |
| Dec 31, 2022 | -8.49 Mn |
| Sep 30, 2022 | -10.01 Mn |
| Jun 30, 2022 | -14.00 Mn |
| Mar 31, 2022 | -12.46 Mn |
| Dec 31, 2021 | -25.37 Mn |
| Sep 30, 2021 | -11.91 Mn |
| Jun 30, 2021 | -5.58 Mn |
| Mar 31, 2021 | -18.87 Mn |